Screener
Amneal Pharmaceuticals, Inc. AMRX Enterprise value
Enterprise value at other companies
Other financials
Where this comes from
Calculated from Amneal Pharmaceuticals, Inc.’s reported figures.
The source filing: Amneal Pharmaceuticals, Inc.’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 5:19 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001723128-26-000031
FAQ
- What is Amneal Pharmaceuticals, Inc.'s enterprise value?
- Amneal Pharmaceuticals, Inc. (AMRX) reported enterprise value of $7.97B in Q2 2026.
- How has Amneal Pharmaceuticals, Inc.'s enterprise value changed year-over-year?
- Amneal Pharmaceuticals, Inc.'s enterprise value increased by 71.3% year-over-year, from $4.65B to $7.97B.
- What is the long-term trend for Amneal Pharmaceuticals, Inc.'s enterprise value?
- Over 5 years (2020 to 2025), Amneal Pharmaceuticals, Inc.'s enterprise value has grown at a 14.4% compound annual growth rate (CAGR), from $3.25B to $6.37B.
- What does enterprise value mean?
- Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.
Ask your AI about Amneal Pharmaceuticals, Inc.'s enterprise value.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude